Endress+Hauser maintains course in ‘difficult’ year
28 Apr 2025
Laboratory and instrumentation supplier Endress+Hauser CEO Dr Peter Selders has reported a year of mixed performance for 2024 but stated the company had “held up well” in a difficult economic period.
Net sales showed slight growth of 0.7% year on year to €3.744 billion while net income of €407.9 million was down 0.2 percent from the prior year.
Remarked Selders: “2024 was a year of many challenges. While Endress+Hauser did not meet all its targets, the company held up well. We made important progress in many areas and have taken our company forward.”
Performance in the US, China and Germany, which comprise the group’s major markets, was described by chief financial officer Dr Luc Schultheiss as subdued but there was more encouraging news from smaller and medium sized markets.
Though German sales ensured overall European sales were down by 0.9 %, those recorded for Italy, France and UK were encouraging. China likewise produced a reduction in Asian sales of 1.9% but growth in two other leading economies on the continent – India and Japan – were good.
And although the US made a less impressive contribution to North American sales, growth in Canada, Brazil and Argentina ensured a 4.2 percent increase in the two American continents.
The greatest increase for any international market was seen in Africa and the Middle East where it growth was reported at 13.3 %.
In 2024 Endress+Hauser invested heavily in people and assets, creating 514 new jobs worldwide, mostly in production, to expand headcount to 17,046. Additionally, 636 people were engaged as apprentices, participants in dual study programs or as external university students.
The group’s €349.3 million investment in new buildings, equipment and IT also surpassed any other year in the group’s history.
Product development featured strongly too: the firm launched 81 products and made 285 first filings at patent offices globally, while R&D expenditure jumped 3% year on year to total €275.6 million.
